DUPONT CAPITAL MANAGEMENT CORP - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 128 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$292,000
-74.3%
4,867
-63.9%
0.01%
-73.1%
Q2 2019$1,137,000
-3.2%
13,477
+9.5%
0.03%
-3.7%
Q1 2019$1,175,000
+34.9%
12,3030.0%0.03%
+28.6%
Q4 2018$871,000
-17.1%
12,3030.0%0.02%
-8.7%
Q3 2018$1,051,000
-26.3%
12,3030.0%0.02%
-32.4%
Q2 2018$1,426,000
+165.5%
12,303
+85.4%
0.03%
+161.5%
Q1 2018$537,000
+38.0%
6,6350.0%0.01%
+44.4%
Q4 2017$389,000
-48.8%
6,635
-59.1%
0.01%
-47.1%
Q3 2017$760,000
+30.1%
16,2330.0%0.02%
+30.8%
Q2 2017$584,000
-37.0%
16,233
-46.1%
0.01%
-38.1%
Q1 2017$927,000
-8.0%
30,0990.0%0.02%
-8.7%
Q4 2016$1,008,000
+25.8%
30,0990.0%0.02%
+27.8%
Q3 2016$801,000
+107.5%
30,099
+129.3%
0.02%
+100.0%
Q1 2016$386,000
-10.9%
13,1280.0%0.01%
-10.0%
Q4 2015$433,000
-8.6%
13,1280.0%0.01%
-16.7%
Q3 2015$474,000
-19.8%
13,1280.0%0.01%
-7.7%
Q2 2015$591,00013,1280.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,599,109$63,277,0008.68%
SENZAR ASSET MANAGEMENT, LLC 566,903$22,432,0006.58%
Sarissa Capital Management LP 105,000$4,155,0001.60%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 136,637$5,407,0001.41%
RA Capital Management 250,000$9,893,0001.17%
BENNETT LAWRENCE MANAGEMENT L L C/NY 110,515$4,373,0000.99%
Ghost Tree Capital, LLC 35,000$1,385,0000.75%
WALL STREET ASSOCIATES 159,100$6,296,0000.65%
BAILARD, INC. 91,500$3,621,0000.56%
EAM Investors, LLC 62,768$2,484,0000.50%
View complete list of ENANTA PHARMACEUTICALS INC shareholders